Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zagozdzon

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Neoplasma|May 30, 1998
Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in miceJ Gołab, R Zagozdzon, T Stokłosa, et al.
International Journal of Cancer|May 3, 1996
Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo resultsW Lasek, A Giermasz, K Kuc, et al.
Anticancer Research|August 6, 2000
Synergistic antitumor effects of a selective proteasome inhibitor and TNF in miceJ Golab, T Stoklosa, A Czajka, et al.
Oncogene|November 5, 2008
NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumorsS Seng, H K Avraham, G Birrane, et al.
Transplantation Proceedings|July 3, 2018
Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant RecipientsA Bujnowska, M Michon, P Konopelski, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasomeC Wójcik, T Stoklosa, A Giermasz, et al.
Leukemia|May 23, 2001
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivoJ Goł b, R Zagozdzon, R Kamiński, et al.
Life Sciences|March 29, 2000
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in miceJ Gołab, K Kozar, R Kamiński, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in miceJ Gołab, T Stokłosa, R Zagozdzon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 5, 1998
Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in miceJ Gołab, T Stokłosa, R Zagozdzon, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Neoplasma|May 30, 1998
Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in miceJ Gołab, R Zagozdzon, T Stokłosa, et al.
International Journal of Cancer|May 3, 1996
Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo resultsW Lasek, A Giermasz, K Kuc, et al.
Anticancer Research|August 6, 2000
Synergistic antitumor effects of a selective proteasome inhibitor and TNF in miceJ Golab, T Stoklosa, A Czajka, et al.
Oncogene|November 5, 2008
NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumorsS Seng, H K Avraham, G Birrane, et al.
Transplantation Proceedings|July 3, 2018
Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant RecipientsA Bujnowska, M Michon, P Konopelski, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 1, 1997
Apoptosis induced in L1210 leukaemia cells by an inhibitor of the chymotrypsin-like activity of the proteasomeC Wójcik, T Stoklosa, A Giermasz, et al.
Leukemia|May 23, 2001
Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivoJ Goł b, R Zagozdzon, R Kamiński, et al.
Life Sciences|March 29, 2000
Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in miceJ Gołab, K Kozar, R Kamiński, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
G-CSF prevents the suppression of bone marrow hematopoiesis induced by IL-12 and augments its antitumor activity in a melanoma model in miceJ Gołab, T Stokłosa, R Zagozdzon, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 5, 1998
Granulocyte-macrophage colony-stimulating factor potentiates antitumor activity of interleukin-12 in melanoma model in miceJ Gołab, T Stokłosa, R Zagozdzon, et al.
Pageof 3